List of works - Xavier Xifró

17beta-estradiol does not protect cerebellar granule cells from excitotoxicity or apoptosis

scientific article published in July 2007

Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease

scientific article

Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington's disease.

scientific article published on 12 August 2010

Analysis of antibodies to neuronal surface antigens in adult opsoclonus–myoclonus

scientific article published on 30 May 2008

BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease

scientific article

Bone morphogenetic protein-6 promotes cerebellar granule neurons survival by activation of the MEK/ERK/CREB pathway

scientific article published on December 2009

Brief exposure to NMDA produces long-term protection of cerebellar granule cells from apoptosis

scientific article published in February 2005

Contribution of caspase-mediated apoptosis to the cell death caused by oxygen-glucose deprivation in cortical cell cultures.

scientific article published in October 2005

Decreased Myocyte Enhancer Factor 2 Levels in the Hippocampus of Huntington's Disease Mice Are Related to Cognitive Dysfunction

scientific article published on 05 August 2020

Delineating the factors and cellular mechanisms involved in the survival of cerebellar granule neurons.

scientific article

Diagnóstico y tratamiento farmacológico del dolor neuropático del lesionado medular: del laboratorio a la clínica

scientific article published in February 2013

Estradiol facilitates neurite maintenance by a Src/Ras/ERK signalling pathway

scientific article published on 14 June 2008

Histamine H2-receptor antagonist ranitidine protects against neural death induced by oxygen-glucose deprivation.

scientific article published on 19 August 2004

Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity.

scientific article published on 31 October 2011

Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease

scientific article

Loss of striatal 90-kDa ribosomal S6 kinase (Rsk) is a key factor for motor, synaptic and transcription dysfunction in Huntington's disease

scientific article published on 6 April 2016

N-methyl-D-aspartate blocks activation of JNK and mitochondrial apoptotic pathway induced by potassium deprivation in cerebellar granule cells.

scientific article published on 27 December 2005

Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice

scientific article

PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression

scientific article

PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.

scientific article

Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6/1 mouse model of Huntington's disease

scientific article published on 7 November 2013

Prostaglandin E2 EP2 activation reduces memory decline in R6/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity.

scientific article published on 11 September 2015

Ras protein activation is a key event in activity-dependent survival of cerebellar granule neurons.

scientific article published on 12 February 2014

Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity.

scientific article published on 4 September 2009

Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity

scientific article (publication date: June 2011)

Striatal-enriched protein tyrosine phosphatase modulates nociception: evidence from genetic deletion and pharmacological inhibition

scientific article published on 11 August 2015

List of works by Xavier Xifró

17beta-estradiol does not protect cerebellar granule cells from excitotoxicity or apoptosis

Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease

Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington's disease.

Analysis of antibodies to neuronal surface antigens in adult opsoclonus–myoclonus

BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease

Bone morphogenetic protein-6 promotes cerebellar granule neurons survival by activation of the MEK/ERK/CREB pathway

Brief exposure to NMDA produces long-term protection of cerebellar granule cells from apoptosis

Contribution of caspase-mediated apoptosis to the cell death caused by oxygen-glucose deprivation in cortical cell cultures.

Decreased Myocyte Enhancer Factor 2 Levels in the Hippocampus of Huntington's Disease Mice Are Related to Cognitive Dysfunction

Delineating the factors and cellular mechanisms involved in the survival of cerebellar granule neurons.

Diagnóstico y tratamiento farmacológico del dolor neuropático del lesionado medular: del laboratorio a la clínica

Estradiol facilitates neurite maintenance by a Src/Ras/ERK signalling pathway

Histamine H2-receptor antagonist ranitidine protects against neural death induced by oxygen-glucose deprivation.

Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity.

Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease

Loss of striatal 90-kDa ribosomal S6 kinase (Rsk) is a key factor for motor, synaptic and transcription dysfunction in Huntington's disease

N-methyl-D-aspartate blocks activation of JNK and mitochondrial apoptotic pathway induced by potassium deprivation in cerebellar granule cells.

Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice

PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression

PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.

Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6/1 mouse model of Huntington's disease

Prostaglandin E2 EP2 activation reduces memory decline in R6/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity.

Ras protein activation is a key event in activity-dependent survival of cerebellar granule neurons.

Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity.

Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity

Striatal-enriched protein tyrosine phosphatase modulates nociception: evidence from genetic deletion and pharmacological inhibition